Review of the risks and benefits of yellow fever vaccination including some new analyses
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of the risks and benefits of yellow fever vaccination including some new analyses
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 11, Issue 4, Pages 427-448
Publisher
Informa UK Limited
Online
2012-05-02
DOI
10.1586/erv.12.6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
- (2011) Mauricio F. Farez ARCHIVES OF NEUROLOGY
- Neurovirulence tests of three 17D yellow fever vaccine strains
- (2011) Philip D. Minor BIOLOGICALS
- Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk
- (2011) S. Kuhn et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?
- (2011) Garth L. Burn et al. FEBS LETTERS
- The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever
- (2011) Emily S Jentes et al. LANCET INFECTIOUS DISEASES
- An Inactivated Cell-Culture Vaccine against Yellow Fever
- (2011) Thomas P. Monath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review
- (2011) Roger E. Thomas et al. VACCINE
- Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model
- (2011) Justin G. Julander et al. VACCINE
- Persistence of yellow fever vaccine RNA in urine
- (2011) Miguel J. Martínez et al. VACCINE
- Suspected Yellow Fever Vaccine-Associated Viscerotropic Adverse Events (1973 and 1978), United States
- (2010) Thomas P. Monath AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Immunogenicity and Tolerability of Yellow Fever Vaccination in 23 French HIV-Infected Patients
- (2010) Thierry Pistone et al. CURRENT HIV RESEARCH
- Detection of Yellow Fever 17D Genome in Urine
- (2010) C. Domingo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Variability in the 2′‐5′‐Oligoadenylate Synthetase Gene Cluster Is Associated with Human Predisposition to Tick‐Borne Encephalitis Virus–Induced Disease
- (2010) Andrey V. Barkhash et al. JOURNAL OF INFECTIOUS DISEASES
- Knowledge, Attitudes, and Practices of Japanese Travelers on Infectious Disease Risks and Immunization Uptake
- (2010) Kyoko Namikawa et al. JOURNAL OF TRAVEL MEDICINE
- Yellow fever vaccination coverage among children in Brazilian capitals
- (2010) Maria Amélia S.M. Veras et al. VACCINE
- Is it time for a new yellow fever vaccine?
- (2010) Edward B. Hayes VACCINE
- WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009
- (2010) Morag Ferguson et al. VACCINE
- Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
- (2010) Thomas P. Monath et al. VACCINE
- Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults
- (2010) Maria Luiza Silva et al. VACCINE
- The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells
- (2010) H. Elbahesh et al. VIROLOGY
- The Need for Organization and Collaboration: Establishing a Thymoma Registry
- (2010) Pascal A. Thomas Thoracic Surgery Clinics
- Incidence of Yellow Fever Vaccine-Associated Neurotropic Disease
- (2009) Thomas Guimard et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Population-based lupus registries: Advancing our epidemiologic understanding
- (2009) S. Sam Lim et al. ARTHRITIS AND RHEUMATISM
- Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected Patients
- (2009) Olivia Veit et al. CLINICAL INFECTIOUS DISEASES
- Yellow fever vaccine—how does it work and why do rare cases of serious adverse events take place?
- (2009) Alan DT Barrett et al. CURRENT OPINION IN IMMUNOLOGY
- Safety of 17D derived yellow fever vaccines
- (2009) Cristina Domingo et al. Expert Opinion On Drug Safety
- Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies
- (2009) Lesley A. Anderson et al. INTERNATIONAL JOURNAL OF CANCER
- Persistent Infection with West Nile Virus Years after Initial Infection
- (2009) Kristy Murray et al. JOURNAL OF INFECTIOUS DISEASES
- Yellow Fever in a Brazilian Family Returning From Vacation in an Endemic Area: Relevant Clinical Features and Epidemiological Issues: Table 1
- (2009) Tânia S. S. Chaves et al. JOURNAL OF TRAVEL MEDICINE
- Yellow Fever Vaccination and Kawasaki Disease
- (2009) Deonilson Schmöeller et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Vaccination as a Triggering Event for Autoimmune Hepatitis
- (2009) Ponni Perumalswami et al. SEMINARS IN LIVER DISEASE
- Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy
- (2009) Anna H. Roukens et al. VACCINE
- Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system
- (2009) Anna P. Durbin et al. VACCINE
- Viscerotropic disease following yellow fever vaccination in Peru
- (2009) Alvaro Whittembury et al. VACCINE
- A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection
- (2009) Kathryn C. Meier et al. PLoS Pathogens
- Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man
- (2009) Jean K. Lim et al. PLoS Pathogens
- Yellow fever vaccines and international travelers
- (2008) Elizabeth D Barnett et al. Expert Review of Vaccines
- Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
- (2008) Denis Gaucher et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters
- (2008) X. Wu et al. JOURNAL OF GENERAL VIROLOGY
- Immune Response during Adverse Events after 17D‐Derived Yellow Fever Vaccination in Europe
- (2008) Hi‐Gung Bae et al. JOURNAL OF INFECTIOUS DISEASES
- Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes
- (2008) Bali Pulendran et al. JOURNAL OF INFECTIOUS DISEASES
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
- (2008) Troy D Querec et al. NATURE IMMUNOLOGY
- Adverse event reports following yellow fever vaccination
- (2008) Nicole P. Lindsey et al. VACCINE
- Treatment of yellow fever
- (2007) Thomas P. Monath ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation